Gender-affirming hormone therapy is not associated with increased cardiovascular risk in transgender women but is in transgender men. This aligns with known effects of oestradiol and testosterone on cardiovascular risk factors. 💖⚧️💪
Read Full Article
#GenderAffirmingCare #TransHealth #HormoneTherapy #CardiovascularRisk #TransgenderAwareness
Read Full Article
#GenderAffirmingCare #TransHealth #HormoneTherapy #CardiovascularRisk #TransgenderAwareness
OUP Academic
Transgender persons receiving gender-affirming hormone therapy: risk of acute cardiovascular events in a Dutch cohort study Open…
AbstractBackground and Aims. Despite favourable effects of oestradiol on cardiovascular risk factors, previous studies found higher risks of cardiovascular
🦄6❤1💩1